name: mdr-745-specialist-guide slug: mdr-745-specialist-guide version: 1.0.2 displayName: "欧盟MDR医疗器械合规|简诗 AI" summary: "提供欧盟医疗器械法规MDR 2017/745合规模式,包括器械分类、技术文档编写、临床证据准备和上市后监管,输出逐条合规指南。" description: "提供欧盟医疗器械法规MDR 2017/745合规模式,包括器械分类、技术文档编写、临床证据准备和上市后监管,输出逐条合规指南。" tags: ["business-operations", "jianshi-ai"]
EU MDR compliance patterns for medical device classification, technical documentation, and clinical evidence.
Classify device under MDR Annex VIII:
| Factor | Class I | Class IIa | Class IIb | Class III |
|---|---|---|---|---|
| Duration | Any | Short-term | Long-term | Long-term |
| Invasiveness | Non-invasive | Body orifice | Surgical | Implantable |
| System | Any | Non-critical | Critical organs | CNS/cardiac |
| Risk | Lowest | Low-medium | Medium-high | Highest |
| Information Use | Condition Severity | Class |
|---|---|---|
| Informs decision | Non-serious | IIa |
| Informs decision | Serious | IIb |
| Drives/treats | Critical | III |
Example 1: Absorbable Surgical Suture - Rule 8 (implantable, long-term) - Duration: > 30 days (absorbed) - Contact: General tissue - Classification: Class IIb
Example 2: AI Diagnostic Software - Rule 11 + MDCG 2019-11 - Function: Diagnoses serious condition - Classification: Class IIb
Example 3: Cardiac Pacemaker - Rule 8 (implantable) - Contact: Central circulatory system - Classification: Class III
Prepare technical file per Annex II and III:
ANNEX II TECHNICAL DOCUMENTATION
├── Device description and UDI-DI
├── Label and instructions for use
├── Design and manufacturing info
├── GSPR compliance matrix
├── Benefit-risk analysis
├── Verification and validation
└── Clinical evaluation report
| Requirement | Evidence | Status |
|---|---|---|
| Safe design (GSPR 1-3) | Risk management file | ☐ |
| Chemical properties (GSPR 10.1) | Biocompatibility report | ☐ |
| Infection risk (GSPR 10.2) | Sterilization validation | ☐ |
| Software requirements (GSPR 17) | IEC 62304 documentation | ☐ |
| Labeling (GSPR 23) | Label artwork, IFU | ☐ |
| Class | Route | NB Involvement |
|---|---|---|
| I | Annex II self-declaration | None |
| Is/Im | Annex II + IX/XI | Sterile/measuring aspects |
| IIa | Annex II + IX or XI | Product or QMS |
| IIb | Annex IX, or Annex X + XI | QMS + tech doc assessment, or type exam + production |
| III | Annex IX, or Annex X + XI | Full QMS + product dossier, or type exam + production |
Develop clinical evidence strategy per Annex XIV:
| Class | Minimum Evidence | Investigation |
|---|---|---|
| I | Risk-benefit analysis | Not typically required |
| IIa | Literature + post-market | May be required |
| IIb | Systematic literature review | Often required |
| III | Comprehensive clinical data | Required (Article 61) |
CER CONTENTS
├── Executive summary
├── Device scope and intended purpose
├── Clinical background (state of the art)
├── Literature search methodology
├── Data appraisal and analysis
├── Safety and performance conclusions
├── Benefit-risk determination
└── PMCF plan summary
Establish PMS system per Chapter VII:
| Component | Requirement | Frequency |
|---|---|---|
| PMS Plan | Article 84 | Maintain current |
| PSUR | Article 86 — Class IIa and higher | Per Art. 86(1) schedule below |
| PMCF Plan | Annex XIV Part B | Update with CER |
| PMCF Report | Annex XIV Part B | Annual (Class III) |
| Vigilance | Articles 87-92 | As events occur |
| Class | Frequency (MDR Art. 86(1)) |
|---|---|
| Class III | Updated at least annually |
| Class IIb (all, incl. implantable) | Updated at least annually |
| Class IIa | When necessary, at least every 2 years |
| Class I | No PSUR — PMS report instead (Art. 85) |
| Timeline | Requirement |
|---|---|
| 2 days | Serious public health threat |
| 10 days | Death or serious deterioration |
| 15 days | Other serious incidents |
Implement UDI system per Article 27:
| Module | Content | Actor |
|---|---|---|
| Actor | Company registration | Manufacturer, AR |
| UDI/Device | Device and variant data | Manufacturer |
| Certificates | NB certificates | Notified Body |
| Clinical Investigation | Study registration | Sponsor |
| Vigilance | Incident reports | Manufacturer |
| Market Surveillance | Authority actions | Competent Authority |
Required elements per Article 13:
7w4.net小葱技能站收录全网优质技能,值得收藏。
references/mdr-classification-guide.md contains:
references/clinical-evidence-requirements.md contains:
references/technical-documentation-templates.md contains:
# Quick gap analysis
python scripts/mdr_gap_analyzer.py --device "Device Name" --class IIa
# JSON output for integration
python scripts/mdr_gap_analyzer.py --device "Device Name" --class III --output json
# Interactive assessment
python scripts/mdr_gap_analyzer.py --interactive
Analyzes device against MDR requirements, identifies compliance gaps, generates prioritized recommendations.
Output includes: - Requirements checklist by category - Gap identification with priorities - Critical gap highlighting - Compliance roadmap recommendations
| Factor | Considerations |
|---|---|
| Designation scope | Covers your device type |
| Capacity | Timeline for initial audit |
| Geographic reach | Markets you need to access |
| Technical expertise | Experience with your technology |
| Fee structure | Transparency, predictability |
获取使用帮助和更多实用 Skill,请关注公众号「简诗 AI」,或在 SkillHub 搜索「简诗 AI」这是一份质量较好的欧盟医疗器械合规指南,内容专业全面,分类规则和流程说明清晰,适合需要了解MDR合规要求的专业人士使用。优点是结构清晰、参考资料丰富、包含实用的分析工具;不足是配置较为简单,缺乏实际使用案例和引导说明,对新用户可能不够友好。总体而言专业性强但实用性和易用性还有提升空间。